Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy.

Smentoch J, Szade J, Żaczek AJ, Eltze E, Semjonow A, Brandt B, Bednarz-Knoll N.

Cancers (Basel). 2019 Sep 12;11(9). pii: E1356. doi: 10.3390/cancers11091356.

2.

BRCAness in prostate cancer.

Bednarz-Knoll N, Eltze E, Semjonow A, Brandt B.

Oncotarget. 2019 Mar 29;10(25):2421-2422. doi: 10.18632/oncotarget.26818. eCollection 2019 Mar 29. No abstract available.

3.

ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.

Nastały P, Filipska M, Morrissey C, Eltze E, Semjonow A, Brandt B, Pantel K, Bednarz-Knoll N.

Transl Res. 2019 Jan;203:49-56. doi: 10.1016/j.trsl.2018.08.007. Epub 2018 Sep 12.

PMID:
30287243
4.

Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.

Omari A, Nastały P, Stoupiec S, Bałabas A, Dąbrowska M, Bielińska B, Huss S, Pantel K, Semjonow A, Eltze E, Brandt B, Bednarz-Knoll N.

Int J Cancer. 2019 Feb 1;144(3):607-614. doi: 10.1002/ijc.31905. Epub 2018 Oct 22.

5.

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.

Obermayr E, Bednarz-Knoll N, Orsetti B, Weier HU, Lambrechts S, Castillo-Tong DC, Reinthaller A, Braicu EI, Mahner S, Sehouli J, Vergote I, Theillet C, Zeillinger R, Brandt B.

Oncotarget. 2017 Nov 16;8(63):106415-106428. doi: 10.18632/oncotarget.22468. eCollection 2017 Dec 5.

6.

Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy.

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A.

Int J Mol Sci. 2015 Feb 11;16(2):3856-69. doi: 10.3390/ijms16023856.

7.

AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.

Grabinski N, Möllmann K, Milde-Langosch K, Müller V, Schumacher U, Brandt B, Pantel K, Jücker M.

Cell Signal. 2014 May;26(5):1021-9. doi: 10.1016/j.cellsig.2014.01.018. Epub 2014 Jan 24.

PMID:
24463007
8.

Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A.

Int J Mol Sci. 2013 Jun 3;14(6):11816-29. doi: 10.3390/ijms140611816.

9.

Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.

Hohensee I, Lamszus K, Riethdorf S, Meyer-Staeckling S, Glatzel M, Matschke J, Witzel I, Westphal M, Brandt B, Müller V, Pantel K, Wikman H.

Am J Pathol. 2013 Jul;183(1):83-95. doi: 10.1016/j.ajpath.2013.03.023. Epub 2013 May 9.

PMID:
23665199
10.

EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.

Vashist YK, Trump F, Gebauer F, Kutup A, Güngör C, Kalinin V, Muddasar R, Vettorazzi E, Yekebas EF, Brandt B, Pantel K, Izbicki JR.

Target Oncol. 2014 Mar;9(1):43-52. doi: 10.1007/s11523-013-0260-2. Epub 2013 Feb 2.

PMID:
23377570
11.

Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk.

Ozel C, Seidel J, Meyer-Staeckling S, Brandt BH, Niggemann B, Zänker KS, Dittmar T.

Cell Commun Signal. 2012 Apr 9;10(1):10. doi: 10.1186/1478-811X-10-10.

12.

Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.

Schulte DM, Müller N, Neumann K, Oberhäuser F, Faust M, Güdelhöfer H, Brandt B, Krone W, Laudes M.

PLoS One. 2012;7(2):e32437. doi: 10.1371/journal.pone.0032437. Epub 2012 Feb 23.

13.

Site-specific chromatin immunoprecipitation: a selective method to individually analyze neighboring transcription factor binding sites in vivo.

Schuch R, Agelopoulos K, Neumann A, Brandt B, Bürger H, Korsching E.

BMC Res Notes. 2012 Feb 20;5:109. doi: 10.1186/1756-0500-5-109.

14.

The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.

Balz LM, Bartkowiak K, Andreas A, Pantel K, Niggemann B, Zänker KS, Brandt BH, Dittmar T.

J Pathol. 2012 Jun;227(2):234-44. doi: 10.1002/path.3991. Epub 2012 Mar 21. Erratum in: J Pathol. 2013 May;230(1):e1.

PMID:
22262199
15.

Quantitative high-resolution genomic analysis of single cancer cells.

Hannemann J, Meyer-Staeckling S, Kemming D, Alpers I, Joosse SA, Pospisil H, Kurtz S, Görndt J, Püschel K, Riethdorf S, Pantel K, Brandt B.

PLoS One. 2011;6(11):e26362. doi: 10.1371/journal.pone.0026362. Epub 2011 Nov 30.

16.

15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells.

Lehtinen L, Vainio P, Wikman H, Reemts J, Hilvo M, Issa R, Pollari S, Brandt B, Oresic M, Pantel K, Kallioniemi O, Iljin K.

J Pathol. 2012 Mar;226(4):674-86. doi: 10.1002/path.3956. Epub 2012 Jan 17.

PMID:
22072156
17.

Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes.

Liedtke C, Packeisen J, Hess KR, Vogt U, Kiesel L, Kersting C, Korsching E, Brandt B, Buerger H.

Eur J Cancer. 2012 Sep;48(13):2066-74. doi: 10.1016/j.ejca.2011.08.006. Epub 2011 Sep 13.

PMID:
21920731
18.

Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.

Grabinski N, Bartkowiak K, Grupp K, Brandt B, Pantel K, Jücker M.

Cell Signal. 2011 Dec;23(12):1952-60. doi: 10.1016/j.cellsig.2011.07.003. Epub 2011 Jul 12.

PMID:
21777670
19.

Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer.

Hungermann D, Schmidt H, Natrajan R, Tidow N, Poos K, Reis-Filho JS, Brandt B, Buerger H, Korsching E.

J Pathol. 2011 Aug;224(4):517-28. doi: 10.1002/path.2938. Epub 2011 Jun 27.

PMID:
21706489
20.

Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplification.

Kasten-Pisula U, Saker J, Eicheler W, Krause M, Yaromina A, Meyer-Staeckling S, Scherkl B, Kriegs M, Brandt B, Grénman R, Petersen C, Baumann M, Dikomey E.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1181-8. doi: 10.1016/j.ijrobp.2011.02.043. Epub 2011 Apr 20.

PMID:
21514063

Supplemental Content

Loading ...
Support Center